Cargando…
Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study
BACKGROUND: Caffeine is available in an ampoule, used via parenteral and enteral routes in preterm neonates to treat apnea of prematurity (AOP) in neonates of gestational age ≥ 35–40 weeks. A longer duration of therapy has a higher risk of medication non-adherence due to higher costs and inappropria...
Autores principales: | Ambreen, Gul, Kumar, Manoj, Ali, Amin, Shah, Syed Akbar Ali, Saleem, Syed Muzafar, Tahir, Ayesha, Salat, Muhammad Sohail, Aslam, Muhammad Shahzad, Hussain, Kashif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645656/ https://www.ncbi.nlm.nih.gov/pubmed/36350877 http://dx.doi.org/10.1371/journal.pone.0275655 |
Ejemplares similares
-
Relationship of caffeine regimen with osteopenia of prematurity in preterm neonates: a cohort retrospective study
por: Kumar, Manoj, et al.
Publicado: (2022) -
Meropenem-induced pancytopenia in a preterm neonate: a case report
por: Hussain, Kashif, et al.
Publicado: (2021) -
Neurodevelopment Outcome of Neonates Treated With Intraventricular Colistin for Ventriculitis Caused by Multiple Drug-Resistant Pathogens—A Case Series
por: Hussain, Kashif, et al.
Publicado: (2021) -
Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
por: Hussain, Kashif, et al.
Publicado: (2021) -
Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
por: Hussain, Kashif, et al.
Publicado: (2022)